Thymidine kinase-independent click chemistry DNADetect™ probes as an EdU alternative for mammalian cell DNA labelling
Macdonald, J. R.; Fisher, G. M.; Braun, A.-S. C.; Thomas, S.; Skinner-Adams, T. S.; Hilko, D. H. H.; Poulsen, S.-A.; Andrews, K. T.
Show abstract
Nucleoside analogues have been powerful tools to study DNA synthesis, cell cycle progression and cellular fate for decades. EdU (5-ethynyl-2'-deoxyuridine), which contains an alkyne handle that allows copper-catalyzed azide-alkyne cycloaddition (CuAAC) to a fluorescent azide in a "click" chemistry reaction, is one of the most frequently utilised nucleoside analogue probes. EdU is transported into cells by nucleoside transporters followed by phosphorylation by thymidine kinase, the first step in thymidine metabolism leading to DNA synthesis. As some organisms like malaria parasites lack the thymidine kinase enzyme and cannot be labelled by EdU or related thymidine analogue probes, we previously designed and validated DNADetect EdU analogues as chemical probes. These probes comprise a masked monophosphate on the 5'-hydroxyl group of the nucleoside sugar moiety that is metabolised directly to EdU monophosphate, bypassing the need for thymidine kinase. Here, we demonstrate that DNADetect probes can be used to label DNA in mammalian cells. DNADetect probes are incorporated into proliferating HeLa cells as efficiently as EdU and outcompeted by thymidine. Additionally, we implement a protocol for best practice use of metabolic chemical probes by using a specifically designed inactive control probe for each active probe. While this approach is commonly applied with chemical probes that modulate protein function, it is yet to be commonly applied with metabolic chemical probes.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication 91%
- Methylene Blue has a potent antiviral activity against SARS-CoV-2 in the absence of UV-activation in vitro 91%
- Nanoparticles with Curcumin and Piperine Modulate Steroid Biosynthesis in Prostate Cancer 91%
Similar papers in this journal
- Alternate dyes for image-based profiling assays 91%
- High Content Phenotypic Profiling in Oesophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery 91%
- TREM2 Hit Discovery Using TRIC Technology: A Proof-of-Concept High-Throughput Screening Approach 90%
Similar papers in this journal
- Methylene Blue Inhibits In Vitro the SARS-CoV-2 Spike - ACE2 Protein-Protein Interaction - A Mechanism That Can Contribute to Its Antiviral Activity Against COVID-19 93%
- Bioluminescent zebrafish transplantation model for drug discovery 91%
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 90%
Similar papers in this journal
- A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) Technology: Development of Targeted Apoptosis Initiators for Cancer Treatment. 93%
- Altering mammalian transcription networking with ADAADi: An inhibitor of ATP-dependent chromatin remodeling 92%
- Cytoprotective effects of (E)-N-(2-(3, 5-dimethoxystyryl) phenyl) furan-2-carboxamide (BK3C231) against 4-nitroquinoline 1-oxide-induced damage in CCD-18Co human colon fibroblast cells 92%
Similar papers in this journal
- Temporal and Spatial Characterization of CUL3KLHL20-driven Targeted Degradation of BET family, BRD Proteins by the Macrocycle-based Degrader BTR2004 91%
- SETDB1 Triple Tudor Domain Ligand, (R,R)-59, Promotes Methylation of Akt1 in Cells 91%
- Rational development of a small-molecule activator of CK1γ2 that decreases C99 and beta-amyloid levels 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.